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PDGF consists of two polypeptide chains, A and B, and all three possible dimers have been isolated from different sour- 
ces. Human PDGF, essentially AB, porcine PDGF (BB) and recombinant PDGF-AA were tested on Swiss 3T3 fibroblasts 
for their ability to stimulate mitogenesis, phosphoinositide turnover and tyrosine phosphorylation of the PDGF receptor. 
When used in saturating amounts, the three isoforms were qually active in inducing mitogenesis. However, PDGF-AA 
was less active than AB and BB to induce the phosphorylation f the receptor and the turnover of phosphoinositides 
(30~ and 50%, respectively). These findings uggest that, in Swiss 3T3 fibroblasts, PDGF receptors ofthe a-type are pres- 
ent in a slightly lower amount than//-type. In addition, the two types of receptor appear to have similar physiological 
functions. 
Platelet-derived growth factor isoform; Tyrosine phosphorylation; Platelet-derived growth factor eceptor; Mitogenesis; 
Phosphoinositide; (Mouse fibroblast) 
1. INTRODUCTION 
The platelet-derived growth factor (PDGF), a 
major  mitogen for connective cells in vitro [1], 
structurally consists of two polypeptide chains 
linked by disulphide bonds [2]. The A and B sub- 
units share 60°70 homology and the B chain is the 
product of the c-sis gene, the normal counterpart 
of the v-sis oncogene carried by the simian sarcoma 
virus [3]. All three possible dimeric forms of PDGF 
have been isolated from different sources: PDGF 
purified from human platelets (hPDGF) mainly 
consists of the AB heterodimer [4], porcine PDGF 
(pPDGF) is a BB homodimer [5], as is the trans- 
forming product of the simian sarcoma virus. 
PDGF-AA is produced by different human 
tumoral cell lines [6,7]. Two types of  highly homo- 
logous PDGF receptors have been identified and 
cloned [8-13]: an cr (or A)-type receptor which in- 
teracts with all three isoforms [12] and a ff (or B)- 
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type receptor, which interacts with BB and AB 
dimers according to several authors [8,11,12] or 
only with BB according to other groups [9,10]. The 
two receptor types are structurally similar and are 
endowed with a protein tyrosine kinase domain 
[12,13]. In human fibroblasts, the two receptor 
classes appear to be expressed in different amounts 
[9] and whereas PDGF-AB and BB are strongly 
mitogenic, PDGF-AA is poorly active [8]. In 
mouse fibroblasts, the situation is not very well 
established although it seems different from 
human cells [12,14,15] and it will be investigated 
further in this paper. 
In addition to the tyrosine kinase activity of the 
receptors, PDGF also stimulates, in several respon- 
sive cells, phosphoinositide breakdown [16-19] 
and, as shown by Escobedo and Williams [20], a 
single type of receptor (B or if) is able to transduce 
the PDGF signal through both tyrosine kinase and 
phosphoinositide turnover pathways. 
We have investigated in mouse Swiss 3T3 fibro- 
blasts the effect of the different isoforms on mito- 
genesis, tyrosine phosphorylation of PDGF recep- 
tor and turnover of phosphoinositides, in order to 
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understand how the two receptor types are express- 
ed in this cell line and to gain informat ion about 
their physiological functions. 
2. MATERIALS  AND METHODS 
2.1. Cells and growth conditions 
Mouse Swiss 3T3 fibroblasts were grown as previously 
described [21]. Quiescent cells were obtained by shifting mono- 
layers to DMEM containing 107o fetal calf serum (FCS) for 24 h. 
2.2. Thymidine incorporation 
DNA synthesis was determined according to Ross et al. [22]. 
Quiescent cells were stimulated for 16 h and labelled for 3 h 
with [3H]thymidine (2.5/LCi/ml). TCA insoluble radioactivity 
was determined. 
2.3. Tyrosine phosphorylation 
Quiescent monolayers in35 mm Petri dishes were incubated 
in 0.5 ml of binding medium [23] containing 0.5o70 BSA for 
8 min at 37°C with the different PDGF isoforms. Total cell pro- 
teins were extracted and analyzed by immunoblotting with anti- 
phosphotyrosine antibodies and ~25I-protein A as described 
[21]. After autoradiography the relative band intensity was 
determined either by counting the 12~I radioactivity associated 
with the receptor band or by densitometric s anning. 
2.4. Phosphoinositide turnover 
Confluent monolayers were incubated with [myo-3H]inositol 
(2/zCi/ml) for 24 h in an inositol-free basal Eagle medium con- 
taining 1% FCS. Cells were then stimulated with PDGF in 
0.5 ml of a Krebs Ringer Hepes olution, with 0.1% BSA, con- 
taining 10 mM LiC1, for 10 min. The cells were extracted with 
TCA and [3H]in0sitol phosphates (InsPs) were separated by 
anion-exchange chromatography [16,17]: 
2.5. PDGF 
hPDGF was purified from human platelets by chromatogra- 
phy on carboxymethyl cellulose, Blue Sepharose, Biogel P-150 
and reverse-phase HPLC [24]. The final preparation analyzed 
by SDS-PAGE under non-reducing conditions followed by 
silver staining revealed a unique band of 28-33 kDa. The 
PDGF-AA homodimer, purified from the conditioned medium 
of yeast cells transfected with PDGF A chain cDNA, was a kind 
gift from Dr C.H. Heldin [8]. Highly purified pPDGF (90070 
pure) was purchased from Bioprocessing. 
2.6. Phosphotyrosine antibodies 
Antibodies against azobenzylphosphonate, which specifically 
crossreact with phosphotyrosine, prepared and affinity-purified 
as described [25] were akind gift from Dr P.M. Comoglio. 
phoinosit ide turnover and tyrosine phosphoryla- 
t ion of the PDGF receptor in Swiss 3T3 fibroblasts. 
Mitogenesis was tested as [3H]thymidine incor- 
porat ion; phosphoinosit ide turnover as the ac- 
cumulat ion of total InsPs (InsP1 + InsP2 + InsP3) 
during 10 min of st imulation in the presence of 
LiCI. Phosphorylat ion of PDGF receptors was 
determined by immunoblot  analysis with phospho- 
tyrosine antibodies in cells stimulated with PDGF 
for 8 min. An  example of a dose response xperi- 
ment on the receptor phosphorylat ion i duced by 
pPDGF is reported in f ig. l ;  the phosphorylated 
form of the receptor is evident in the autoradiogra- 
phy as a 170 kDa band and the band intensity is a 
funct ion of the PDGF concentration. 
For the three responses the data were calculated 
as the difference between the values obtained on 
stimulated cells and the basal value (unstimulated 
cells), and were expressed as a percentage of the 
maximal one. This made it possible to compare the 
effects of a single isoform on the three different 
physiological responses. 
In the upper panel of fig.2, the results obtained 
with hPDGF are reported. The EDso for mito- 
genesis is 8 ng /ml  whereas the maximal response is 
achieved at about 25 ng/ml .  For InsPs accumula- 
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3. RESULTS AND DISCUSSION 
The dose-dependent effects of PDGF purified 
from human platelets, which mainly consists of the 
AB heterodimer [4], pPDGF (BB) and recombi- 
nant  PDGF-AA were tested on mitogenesis, phos- 
Fig. 1. PDGF-induced tyrosine phosphorylation f the PDGF 
receptor. Swiss 3T3 fibroblasts were stimulated for 8 rain with 
10, 30, 100, 300 and 1000 ng/ml of pPDGF. P-tyr containing 
proteins were analyzed with P-tyr antibodies as reported in sec- 
tion 2. The data were quantitated and reported in the middle 
panel of fig.2. 
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Fig.2. Dose-dependent effects of the three isoforms of PDGF on 
DNA synthesis, InsPs accumulation and tyrosine phosphoryla- 
tion of the PDGF receptor. Quiescent Swiss 3T3 fibroblasts 
were stimulated with different concentrations of hPDGF (AB, 
upper panel), with pPDGF (BB, middle panel) and with recom- 
binant PDGF-AA. Mitogenic activity (e), InsPs accumulation 
(z~) and tyrosine phosphorylation of the PDGF receptor (m) 
were tested as reported in section 2. For each kind of measure- 
ment he activity of unstimulated cultures (basal) was subtracted 
from that of the stimulated ones and the data are expressed as 
a percentage of the maximal value. For InsPs accumulation and 
mitogenesis the data are the average of three independent deter- 
minations. 
tion and receptor phosphorylation the dose- 
response curves are shifted to the right with half- 
maximal responses at 18 and 27 ng/ml, respec- 
tively. 
The behaviour observed with pPDGF (middle 
panel of fig.2) is similar, the ED~o being 9, 18 and 
50 ng/ml for the three responses. Moreover, in 
these cells also PDGF-AA was able to elicit the 
same responses: as shown in the lower panel of 
fig.2, the general pattern is similar to that observed 
with the other two dimers, but the EDso values are 
lower (1.5, 6 and 5 ng/ml). 
Thus, in Swiss 3T3 fibroblasts the three isoforms 
stimulate mitogenesis, phosphoinositide turnover 
and receptor phosphorylation. I  every case, the 
dose-effect curve for mitogenesis was shifted to- 
ward lower concentrations with respect to the other 
two responses. This observation can be explained 
by the major differences in the protocols that have 
to be used for the three assays: determination of
DNA synthesis nvolves a 16 h exposure to PDGF, 
whereas for the two other responses, cells are 
stimulated with PDGF for only 10 and 8 min. 
Moreover, for mitogenesis not only the concentra- 
tion of the ligand but also the total amount of 
PDGF present in the assay may be critical. 
In addition, these data indicate that a maximal 
stimulation of mitogenesis can be obtained even at 
PDGF concentrations that do not allow maximal 
stimulation of phosphoinositide turnover and of 
receptor phosphorylation. 
Whereas the concentrations of human and por- 
cine PDGF which.gave half-maximal stimulation 
were very close, but that found for PDGF-AA was 
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Fig.3. Effect of saturating concentrations of the three isoforms 
on thymidine incorporation, phosphoinositide hydrolysis and 
PDGF receptor phosphorylation. [3H]thymidine incorporation 
(left panel): cells were stimulated with 50 ng/ml of PDGF AB, 
50 ng/ml BB and 30 ng/ml AA. Incorporation of unstimulated 
cells was 1095 + 240 cpm. InsPs accumulation (central panel) 
and PDGF receptor phosphorylation (right panel): cells were 
stimulated with 250 ng/ml of PDGF-AB, 500 ng/ml BB and 
100ng/ml AA. For InsPs accumulation basal value was 
932 + 122. The data for receptor phosphorylation were quan- 
titated from fig.4 and are the average of two determinations. 
For mitogenesis and InsPs accumulation the data are the 
average of three determinations and standard eviations are in- 
dicated. The data are expressed as Acpm ove the basal. 
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lower. This difference may be due to differences in
the degree of purity of the three preparations or to 
possible difficulties in the determination f the real 
concentration of the factors, due to the fact that 
the three factors come from different sources. 
The determination of the dose-response curves 
made it possible to compare the effects of the three 
isoforms when present at saturating concentra- 
tions: the left panel of fig.3 shows that at these con- 
centrations the human PDGF, porcine PDGF and 
PDGF-AA induce the same mitogenic response, 
also equivalent to that determined in cells 
stimulated with 10070 serum (not shown). Instead, 
in the case of phosphoinositide turnover (central 
panel of fig.3), the response induced by AA is 
about 5007o f those of AB and BB (statistical 
analysis of the data indicated that the difference 
between AA and BB and the difference between 
AA and AB were highly significant). 
Tyrosine phosphorylation f PDGF receptors in- 
duced by the three isoforms is shown in fig.4 and 
quantitated in the right panel of fig.3. It is evident 
that also in this case PDGF-AA is less effective 
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F ig.4. Tyrosine phosphory lat ion of PDGF receptor induced by 
saturat ing concentrat ions of the three dif ferent isoforms. Cells 
received no addit ion,  or PDGF-AA (100 ng /ml )  or PDGF-BB 
(500 ng /ml )  or PDGF-AB (250 ng/ml ) .  
(about 30°7o) than the two other forms. Fig.4 also 
shows that the bands phosphorylated in response 
to AA, AB and BB have the same apparent 
molecular weight, although minor differences 
would not have been detected. 
Activation of the receptor kinase and its auto- 
phosphorylation occur at the receptor level; ac- 
cumulation of InsPs, which is also a short-term 
response, is mediated by other transducing ele- 
ment(s) in addition to the receptors; instead DNA 
synthesis is the result of a long series of cascade 
events during which amplification may occur at 
different levels as may be suggested by the finding 
that the ligand concentration which gives half max- 
imal stimulation for DNA synthesis i  lower than 
EDso for the other two responses. Whereas the 
responses induced by PDGF-AA are exclusi~gely 
mediated by the a-type receptors, those induced by 
PDGF-BB are mediated by both receptor types. It 
is still debated whether the AB heterodimer inter- 
acts with both receptors as some authors report 
[8,11,12] or whether it only interacts with the a- 
type [9,10]. PDGF purified from human platelets 
contains a certain amount of PDGF-BB, in addi- 
tion to the heterodimer [4] and thus we cannot 
distinguish between these two possibilities. How- 
ever, what is clearly indicated by our data is that in 
Swiss 3T3 fibroblast a-type receptors are present in 
sufficient amounts to elicit the same mitogenic 
response as that observed when also fl-type recep- 
tors are activated. On the other hand, stimulation 
of immediate events uch as receptor phosphoryla- 
tion and phospoinositide turnover, elicited by ac- 
tivation of both (a and ~?) is at least double com- 
pared to that mediated by a-receptors alone. This 
suggests that a-receptors are present in a slightly 
smaller amount than /~-type in Swiss 3T3 
fibroblasts, in accordance with the data of 
Kazlauskas [141. 
This situation appears to be different from that 
observed in human fibroblasts, in which the AA 
form is poorly active [8] and a-receptors are 
10-15070 of the totals [91. 
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